GOLD 2018 Highlights: A New Approach to COPD Management

By clicking the continue button above, I certify that I have read the CME statements below.

Presented by the American Lung Association

A Series of CME-certified Activities


Long Beach


Thursday, September 27, 2018
Registration: 6:30pm - 7:00pm
CME Program: 7:00pm - 8:00pm

Atlanta Fish Market
265 Pharr Road NE
Atlanta, GA 30305 

Overlook A Room 

Thursday, October 18, 2018
Registration: 6:30pm - 7:00pm
CME Program: 7:00pm - 8:00pm

Parkers' Lighthouse 
435 Shoreline Village Dr.
Long Beach, CA 90802

Lantern Room

Thursday, November 15, 2018 
Registration: 6:30pm - 7:00pm 
CME Program: 7:00pm - 8:00pm

Lonesome Dove Western Bistro
2406  N Main St.
Fort Worth, TX 76164

La Cava Room


Program Overview
COPD is underdiagnosed, with up to 60% of individuals with obstructive lung disease undiagnosed and undertreated and most patients not receiving a long-acting maintenance therapy. Recent publication of the 2018 GOLD Report has provided comprehensive recommendations for the diagnosis, assessment, and management of COPD. Some of the most important factors regarding clinician uptake of the recommendations include: lack of familiarity or delayed adoption of GOLD 2018 therapeutic strategy; under-treatment or mistreatment based on disease severity, lack of individualization of management plans, and a lack of patient self-management support.

GOLD 2018 Highlights: A New Approach to COPD Management  will review the new recommendations and enable clinicians to apply the assessment and management strategies incorporating the latest evidence to guide development of individualized management plans for patients with COPD. 

Welcome and Introductions
GOLD 2018 Report Highlights
Implementation of COPD Guidelines in Practice
Q&A Session and Activity Roundup 

Target Audience
This activity is intended for pulmonologists, advanced practice nurses, respiratory therapists, and other healthcare professionals treating COPD in the community setting. 

Educational Objectives
At the conclusion of this activity, participants should be able to demonstrate the ability to:

  •  Discuss the new recommendations of the GOLD 2018 therapeutic strategy and its impacts on the diagnosis, assessment, and treatment of COPD
  • Apply GOLD 2018 assessment and management strategies, incorporating the latest clinical evidence to guide development of individualized management plans

Steering Committee

  Nicola A. Hanania, MD, MS
  Associate Professor of Medicine
  Section of Pulmonary and Critical Care Medicine
  Director, Airways Clinical Research Center
  Baylor College of Medicine
  Houston, TX


 Imre Noth, MD 
 Dudley F. Rochester Professor of Medicine
 Chief, Division of Pulmonary and Critical Care Medicine
 University of Virginia
 Charlottesville, VA


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Potomac Center for Medical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information about the accreditation of this program, please email:

Disclosure Information
Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners. The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.

FDA Disclosure
The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

Method of Participation
To complete the activity and receive credit, the participant must attend the program and complete the evaluation form. A CME certificate will be presented after submission of a completed evaluation form. There is no fee associated with this program.

Special Services
Event staff will be glad to assist you with any special needs. Please email at least 5 days prior to the program.

Jointly provided by the Potomac Center for Medical Education and Rockpointe


This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Click the "Continue" button below to register.